Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration | Patent Publication Number 20130253026

US 20130253026 A1
Patent NumberUS 09000021 B2
Application Number13838267
Filled DateMar 15, 2013
Priority DateMar 20, 2012
Publication DateSep 26, 2013
Original AssigneeEagle Pharmaceuticals Inc.
Current AssigneeJpmorgan Chase Bank
Inventor/ApplicantsScott L. Tarriff
Srikanth Sundaram
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.